Nu Skin Enterprises, Inc. Logo

Nu Skin Enterprises, Inc.

NUS

(2.8)
Stock Price

7,58 USD

-10.62% ROA

-18.91% ROE

-2.16x PER

Market Cap.

320.575.320,00 USD

66.8% DER

2.79% Yield

-8.05% NPM

Nu Skin Enterprises, Inc. Stock Analysis

Nu Skin Enterprises, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nu Skin Enterprises, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (1x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past five years, consistently delivering higher returns to investors.

3 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

4 ROE

ROE in an average range (7.95%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 ROA

The stock's ROA (4.52%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 DER

The stock maintains a fair debt to equity ratio (65%), indicating a reasonable balance between the money it owes and the ownership it possesses.

7 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

8 Buffet Intrinsic Value

The company's stock seems undervalued (167) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

9 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

11 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

Nu Skin Enterprises, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nu Skin Enterprises, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Nu Skin Enterprises, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nu Skin Enterprises, Inc. Revenue
Year Revenue Growth
1995 358.600.000
1996 678.600.000 47.16%
1997 890.500.000 23.8%
1998 913.500.000 2.52%
1999 894.200.000 -2.16%
2000 879.758.000 -1.64%
2001 885.621.000 0.66%
2002 964.067.000 8.14%
2003 986.457.000 2.27%
2004 1.137.864.000 13.31%
2005 1.180.930.000 3.65%
2006 1.115.409.000 -5.87%
2007 1.157.667.000 3.65%
2008 1.247.646.000 7.21%
2009 1.331.058.000 6.27%
2010 1.537.259.000 13.41%
2011 1.743.991.000 11.85%
2012 2.169.664.000 19.62%
2013 3.176.718.000 31.7%
2014 2.569.495.000 -23.63%
2015 2.247.047.000 -14.35%
2016 2.207.797.000 -1.78%
2017 2.279.099.000 3.13%
2018 2.679.008.000 14.93%
2019 2.420.416.000 -10.68%
2020 2.581.934.000 6.26%
2021 2.695.669.000 4.22%
2022 2.225.659.000 -21.12%
2023 1.995.088.000 -11.56%
2023 1.969.131.000 -1.32%
2024 1.756.324.000 -12.12%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nu Skin Enterprises, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 14.900.000 100%
2013 18.000.000 17.22%
2014 18.900.000 4.76%
2015 20.100.000 5.97%
2016 24.300.000 17.28%
2017 22.000.000 -10.45%
2018 23.000.000 4.35%
2019 30.100.000 23.59%
2020 23.300.000 -29.18%
2021 27.200.000 14.34%
2022 23.300.000 -16.74%
2023 0 0%
2023 22.600.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nu Skin Enterprises, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1995 0
1996 0 0%
1997 503.600.000 100%
1998 533.600.000 5.62%
1999 612.800.000 12.92%
2000 640.003.000 4.25%
2001 636.057.000 -0.62%
2002 0 0%
2003 289.925.000 100%
2004 333.263.000 13%
2005 354.223.000 5.92%
2006 353.412.000 -0.23%
2007 361.242.000 2.17%
2008 364.253.000 0.83%
2009 378.336.000 3.72%
2010 401.418.000 5.75%
2011 436.177.000 7.97%
2012 505.449.000 13.71%
2013 640.028.000 21.03%
2014 622.301.000 -2.85%
2015 561.463.000 -10.84%
2016 554.153.000 -1.32%
2017 564.514.000 1.84%
2018 662.302.000 14.76%
2019 615.970.000 -7.52%
2020 646.848.000 4.77%
2021 666.395.000 2.93%
2022 555.769.000 -19.91%
2023 523.528.000 -6.16%
2023 546.858.000 4.27%
2024 471.684.000 -15.94%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nu Skin Enterprises, Inc. EBITDA
Year EBITDA Growth
1995 60.300.000
1996 130.900.000 53.93%
1997 151.800.000 13.77%
1998 210.800.000 27.99%
1999 164.300.000 -28.3%
2000 122.022.000 -34.65%
2001 95.527.000 -27.74%
2002 130.299.000 26.69%
2003 141.143.000 7.68%
2004 158.038.000 10.69%
2005 158.661.000 0.39%
2006 128.932.000 -23.06%
2007 145.865.000 11.61%
2008 150.203.000 2.89%
2009 175.750.000 14.54%
2010 226.511.000 22.41%
2011 240.715.000 5.9%
2012 340.844.000 29.38%
2013 554.112.000 38.49%
2014 352.188.000 -57.33%
2015 244.702.000 -43.93%
2016 231.104.000 -5.88%
2017 274.483.000 15.8%
2018 382.232.000 28.19%
2019 267.426.000 -42.93%
2020 331.555.000 19.34%
2021 337.732.000 1.83%
2022 207.835.000 -62.5%
2023 -105.460.000 297.07%
2023 137.658.000 176.61%
2024 165.584.000 16.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nu Skin Enterprises, Inc. Gross Profit
Year Gross Profit Growth
1995 264.000.000
1996 490.800.000 46.21%
1997 666.100.000 26.32%
1998 744.400.000 10.52%
1999 775.700.000 4.04%
2000 768.018.000 -1%
2001 707.538.000 -8.55%
2002 773.199.000 8.49%
2003 809.912.000 4.53%
2004 946.653.000 14.44%
2005 974.767.000 2.88%
2006 920.206.000 -5.93%
2007 948.384.000 2.97%
2008 1.019.049.000 6.93%
2009 1.087.410.000 6.29%
2010 1.264.828.000 14.03%
2011 1.421.367.000 11.01%
2012 1.816.512.000 21.75%
2013 2.670.912.000 31.99%
2014 2.091.061.000 -27.73%
2015 1.757.537.000 -18.98%
2016 1.707.340.000 -2.94%
2017 1.777.021.000 3.92%
2018 2.044.868.000 13.1%
2019 1.838.996.000 -11.19%
2020 1.923.906.000 4.41%
2021 2.020.446.000 4.78%
2022 1.594.744.000 -26.69%
2023 1.169.068.000 -36.41%
2023 1.357.281.000 13.87%
2024 1.228.708.000 -10.46%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nu Skin Enterprises, Inc. Net Profit
Year Net Profit Growth
1995 40.200.000
1996 81.700.000 50.8%
1997 93.600.000 12.71%
1998 103.900.000 9.91%
1999 86.700.000 -19.84%
2000 61.700.000 -40.52%
2001 50.313.000 -22.63%
2002 64.843.000 22.41%
2003 67.876.000 4.47%
2004 77.674.000 12.61%
2005 74.033.000 -4.92%
2006 32.817.000 -125.59%
2007 43.872.000 25.2%
2008 65.347.000 32.86%
2009 89.845.000 27.27%
2010 136.051.000 33.96%
2011 153.330.000 11.27%
2012 221.645.000 30.82%
2013 364.888.000 39.26%
2014 189.176.000 -92.88%
2015 133.046.000 -42.19%
2016 143.086.000 7.02%
2017 129.437.000 -10.54%
2018 121.887.000 -6.19%
2019 173.553.000 29.77%
2020 191.355.000 9.3%
2021 147.266.000 -29.94%
2022 104.778.000 -40.55%
2023 -147.820.000 170.88%
2023 8.595.000 1819.84%
2024 -473.032.000 101.82%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nu Skin Enterprises, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1995 1
1996 1 100%
1997 1 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 100%
2005 1 0%
2006 0 0%
2007 1 0%
2008 1 100%
2009 1 0%
2010 2 50%
2011 2 0%
2012 4 33.33%
2013 6 50%
2014 3 -100%
2015 2 -50%
2016 3 0%
2017 2 0%
2018 2 0%
2019 3 33.33%
2020 4 0%
2021 3 -50%
2022 2 0%
2023 -3 200%
2023 0 0%
2024 -10 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nu Skin Enterprises, Inc. Free Cashflow
Year Free Cashflow Growth
1995 59.600.000
1996 115.500.000 48.4%
1997 85.300.000 -35.4%
1998 71.500.000 -19.3%
1999 -13.000.000 650%
2000 20.358.000 163.86%
2001 59.291.000 65.66%
2002 92.090.000 35.62%
2003 85.508.000 -7.7%
2004 95.354.000 10.33%
2005 83.216.000 -14.59%
2006 38.134.000 -118.22%
2007 25.917.000 -47.14%
2008 87.300.000 70.31%
2009 113.729.000 23.24%
2010 134.100.000 15.19%
2011 182.506.000 26.52%
2012 214.331.000 14.85%
2013 345.073.000 37.89%
2014 -157.940.000 318.48%
2015 265.487.000 159.49%
2016 225.042.000 -17.97%
2017 242.399.000 7.16%
2018 132.367.000 -83.13%
2019 111.864.000 -18.33%
2020 315.318.000 64.52%
2021 72.967.000 -332.14%
2022 49.006.000 -48.89%
2023 60.149.000 18.53%
2023 0 0%
2024 43.084.001 100%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nu Skin Enterprises, Inc. Operating Cashflow
Year Operating Cashflow Growth
1995 65.000.000
1996 121.200.000 46.37%
1997 92.700.000 -30.74%
1998 118.600.000 21.84%
1999 30.300.000 -291.42%
2000 43.388.000 30.17%
2001 74.417.000 41.7%
2002 111.116.000 33.03%
2003 109.026.000 -1.92%
2004 130.350.000 16.36%
2005 114.100.000 -14.24%
2006 75.795.000 -50.54%
2007 48.653.000 -55.79%
2008 103.307.000 52.9%
2009 133.944.000 22.87%
2010 187.883.000 28.71%
2011 224.315.000 16.24%
2012 310.976.000 27.87%
2013 530.176.000 41.34%
2014 -56.464.000 1038.96%
2015 322.109.000 117.53%
2016 275.263.000 -17.02%
2017 302.555.000 9.02%
2018 202.738.000 -49.23%
2019 177.931.000 -13.94%
2020 379.141.000 53.07%
2021 141.582.000 -167.79%
2022 108.062.000 -31.02%
2023 118.639.000 8.92%
2023 0 0%
2024 51.207.000 100%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nu Skin Enterprises, Inc. Capital Expenditure
Year Capital Expenditure Growth
1995 5.400.000
1996 5.700.000 5.26%
1997 7.400.000 22.97%
1998 47.100.000 84.29%
1999 43.300.000 -8.78%
2000 23.030.000 -88.02%
2001 15.126.000 -52.25%
2002 19.026.000 20.5%
2003 23.518.000 19.1%
2004 34.996.000 32.8%
2005 30.884.000 -13.31%
2006 37.661.000 17.99%
2007 22.736.000 -65.64%
2008 16.007.000 -42.04%
2009 20.215.000 20.82%
2010 53.783.000 62.41%
2011 41.809.000 -28.64%
2012 96.645.000 56.74%
2013 185.103.000 47.79%
2014 101.476.000 -82.41%
2015 56.622.000 -79.22%
2016 50.221.000 -12.75%
2017 60.156.000 16.52%
2018 70.371.000 14.52%
2019 66.067.000 -6.51%
2020 63.823.000 -3.52%
2021 68.615.000 6.98%
2022 59.056.000 -16.19%
2023 58.490.000 -0.97%
2023 0 0%
2024 8.122.999 100%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nu Skin Enterprises, Inc. Equity
Year Equity Growth
1995 61.800.000
1996 107.800.000 42.67%
1997 177.500.000 39.27%
1998 254.600.000 30.28%
1999 309.400.000 17.71%
2000 366.733.000 15.63%
2001 379.890.000 3.46%
2002 386.486.000 1.71%
2003 290.248.000 -33.16%
2004 296.233.000 2.02%
2005 354.628.000 16.47%
2006 318.980.000 -11.18%
2007 275.009.000 -15.99%
2008 316.180.000 13.02%
2009 375.687.000 15.84%
2010 471.249.000 20.28%
2011 574.236.000 17.93%
2012 590.612.000 2.77%
2013 858.619.000 31.21%
2014 942.438.000 8.89%
2015 825.621.000 -14.15%
2016 664.070.000 -24.33%
2017 704.596.000 5.75%
2018 781.867.000 9.88%
2019 875.289.000 10.67%
2020 894.271.000 2.12%
2021 912.772.000 2.03%
2022 897.296.000 -1.72%
2023 821.968.000 -9.16%
2023 822.187.000 0.03%
2024 686.164.000 -19.82%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nu Skin Enterprises, Inc. Assets
Year Assets Growth
1995 118.200.000
1996 331.700.000 64.37%
1997 352.400.000 5.87%
1998 606.400.000 41.89%
1999 643.200.000 5.72%
2000 590.803.000 -8.87%
2001 582.352.000 -1.45%
2002 611.838.000 4.82%
2003 623.747.000 1.91%
2004 609.737.000 -2.3%
2005 678.866.000 10.18%
2006 664.849.000 -2.11%
2007 683.243.000 2.69%
2008 709.772.000 3.74%
2009 748.449.000 5.17%
2010 892.224.000 16.11%
2011 990.956.000 9.96%
2012 1.152.907.000 14.05%
2013 1.821.062.000 36.69%
2014 1.614.434.000 -12.8%
2015 1.505.843.000 -7.21%
2016 1.474.045.000 -2.16%
2017 1.589.872.000 7.29%
2018 1.694.446.000 6.17%
2019 1.769.006.000 4.21%
2020 1.957.076.000 9.61%
2021 1.906.480.000 -2.65%
2022 1.820.970.000 -4.7%
2023 1.806.463.000 -0.8%
2023 1.793.091.000 -0.75%
2024 1.585.972.000 -13.06%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nu Skin Enterprises, Inc. Liabilities
Year Liabilities Growth
1995 56.400.000
1996 223.900.000 74.81%
1997 174.900.000 -28.02%
1998 351.800.000 50.28%
1999 333.800.000 -5.39%
2000 224.070.000 -48.97%
2001 202.462.000 -10.67%
2002 225.352.000 10.16%
2003 333.499.000 32.43%
2004 313.504.000 -6.38%
2005 324.238.000 3.31%
2006 345.869.000 6.25%
2007 408.234.000 15.28%
2008 393.592.000 -3.72%
2009 372.762.000 -5.59%
2010 420.975.000 11.45%
2011 416.720.000 -1.02%
2012 562.295.000 25.89%
2013 962.443.000 41.58%
2014 671.996.000 -43.22%
2015 680.222.000 1.21%
2016 809.975.000 16.02%
2017 885.276.000 8.51%
2018 912.579.000 2.99%
2019 893.717.000 -2.11%
2020 1.062.805.000 15.91%
2021 993.708.000 -6.95%
2022 923.674.000 -7.58%
2023 984.495.000 6.18%
2023 970.904.000 -1.4%
2024 899.808.000 -7.9%

Nu Skin Enterprises, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
37.11
Net Income per Share
-2.99
Price to Earning Ratio
-2.16x
Price To Sales Ratio
0.17x
POCF Ratio
2.01
PFCF Ratio
3
Price to Book Ratio
0.47
EV to Sales
0.34
EV Over EBITDA
6.74
EV to Operating CashFlow
3.91
EV to FreeCashFlow
5.84
Earnings Yield
-0.46
FreeCashFlow Yield
0.33
Market Cap
0,32 Bil.
Enterprise Value
0,62 Bil.
Graham Number
30.47
Graham NetNet
-9.89

Income Statement Metrics

Net Income per Share
-2.99
Income Quality
-1.08
ROE
-0.19
Return On Assets
-0.09
Return On Capital Employed
0.03
Net Income per EBT
0.95
EBT Per Ebit
-3.95
Ebit per Revenue
0.02
Effective Tax Rate
0.05

Margins

Sales, General, & Administrative to Revenue
0.28
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.68
Operating Profit Margin
0.02
Pretax Profit Margin
-0.08
Net Profit Margin
-0.08

Dividends

Dividend Yield
0.03
Dividend Yield %
2.79
Payout Ratio
-0.3
Dividend Per Share
0.18

Operating Metrics

Operating Cashflow per Share
3.21
Free CashFlow per Share
2.15
Capex to Operating CashFlow
0.33
Capex to Revenue
0.03
Capex to Depreciation
0.74
Return on Invested Capital
0.03
Return on Tangible Assets
-0.11
Days Sales Outstanding
14.16
Days Payables Outstanding
22.16
Days of Inventory on Hand
148.96
Receivables Turnover
25.77
Payables Turnover
16.47
Inventory Turnover
2.45
Capex per Share
1.06

Balance Sheet

Cash per Share
4,69
Book Value per Share
13,81
Tangible Book Value per Share
10.02
Shareholders Equity per Share
13.81
Interest Debt per Share
9.48
Debt to Equity
0.67
Debt to Assets
0.29
Net Debt to EBITDA
3.28
Current Ratio
2.12
Tangible Asset Value
0,50 Bil.
Net Current Asset Value
-0,25 Bil.
Invested Capital
1034151000
Working Capital
0,35 Bil.
Intangibles to Total Assets
0.12
Average Receivables
0,07 Bil.
Average Payables
0,03 Bil.
Average Inventory
254547000
Debt to Market Cap
1.43

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nu Skin Enterprises, Inc. Dividends
Year Dividends Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 100%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 2 0%
2021 2 0%
2022 2 0%
2023 1 0%
2024 0 0%

Nu Skin Enterprises, Inc. Profile

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

CEO
Mr. Ryan S. Napierski
Employee
3.700
Address
75 West Center Street
Provo, 84601

Nu Skin Enterprises, Inc. Executives & BODs

Nu Skin Enterprises, Inc. Executives & BODs
# Name Age
1 Mr. Steve Keith Hatchett
Executive Vice President & Chief Product Officer
70
2 Dr. Joseph Y. Chang Ph.D.
Executive Vice President & Chief Scientific Officer
70
3 Mr. Steven J. Lund
Co-Founder & Executive Chairman of the Board
70
4 Mr. Ryan S. Napierski
President, Chief Executive Officer & Director
70
5 Mr. Chayce David Clark
Executive Vice President & General Counsel
70
6 Mr. Blake M. Roney
Founder
70
7 Mr. Mark L. Adams
Chief Information Officer
70
8 Ms. Sandra N. Tillotson
Founder
70
9 Mr. James D. Thomas
Executive Vice President, Chief Accounting Officer & Chief Financial Officer
70
10 Mr. Joe Sueper
Senior Vice President & Chief Technology Officer
70

Nu Skin Enterprises, Inc. Competitors